1Fabrizi F, Lunghi G, Guarnori I, et al. Hepatitis C virus genotypes in chronic dialysis patients[J]. Nephrol Dial Transplant, 1996,11:679-683.
2CDC Update. Universal precautions for prevention of transmission of human immunodefieieney virus, hepatitis B virus and other blood borne pathogens in healthcare settings [J]. MMWR, 1988, 37:37?-382.
3Centers for Disease Control and Prevention: Recommendations for preventing transmission of infections among chronic hemodialysis patients[J].Morb Mort Weekly Rep, 2001,50 (RR-5):1-3.
4Alfurayh O,Sabeel A ,Al Ahdal MN,et al. Hand Contamination with Hepatitis C Virus in Staff Looking after Hepati tis C-Positive Hemodialysis Patients[J]. Am J Nephrol, 2000,20:103 -106.
5Meyers CM, Seeff LB, Stehman-Breen CO, et al. Hepatitis C and renal disease : an update[J]. An J Kidney Dis, 2003,42: 631 -657.
6Stevens CE, Alter HJ, Taylor PEet al. Hepatitis B vaccine in patients receiving hemodialysis: Immunogenicity and efficacy[J]. N Engl J Med, 1984, 311:496- 501.
7Oirndt M, Kohler H. Hepatitis B virus infection in hemodialysis patients. Semin Nephrol, 2002,22:340 -350.
8Najem GR, Louria DB, Thind IS et al. The role of surveillance and an isolation hemodialysis center[J]. JAVA, 1981, 245:153-157.
9Alter MJ, Favero MS, Maynard JE. Impact of infection control strategies on the incidence of dialysis associ ated hepatitis in the United States[J]. J Infect Dis, 1986, 153: I149-I151.
10Jadoul M, Cornu C, van Ypersele de Strihou C, The Universitaires Cliniques St-Lue (UCL) Collaborative Group: Universal precautions prevent hepatitis C virus transmission: a 54 month follow-up of the Belgianmulticenter study[J]. Kidney Int, 1998,53:1022-1025.
1Pittet D. Improving Adherence to Hand HygienePractice:A Multidisciplimary Approech [J].EmergingInfectious Diseases, 2012,58 ( 28 ) : 234.
2Adib-Hajbaghery M, Molavizadeh N , Alavi NM. Qualityof care of vascular access in hemodialysis patients in ahemodialysis center in Iran [J]. Journal of VascularNursing, 2012, 25(46):24.
